The association between tumor necrosis factor alpha promoter polymorphisms and ankylosing spondylitis: A meta-analysis

Human Immunology

Volumn 74, Issue 10, 2013, Pages 1357-1362

  Ma, Bo ^a,b   Yang, Bing ^a   Guo, Hainiu ^a   Wang, Yihong ^a   Zhang, Dayi ^a   Zhang, Yuan ^a   Xiao, Zhengquan ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b Beijing Beiya Orthopedics Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANKYLOSING SPONDYLITIS; ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; DNA POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTEMATIC REVIEW;

ALLELES; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PUBLICATION BIAS; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883829986     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.06.037     Document Type: Article

References (46)

1. Braun J., Sieper J. Ankylosing spondylitis. Lancet 2007, 369:1379-1390.
2. low/- regulatory T-cells and serum immunoglobulin A in patients with new-onset ankylosing spondylitis. J Int Med Res 2011, 39:1968-1974.
3. Robinson P.C., Brown M.A. The genetics of ankylosing spondylitis and axial spondyloarthritis. Rheum Dis Clin North Am 2012, 38:539-553.
4. *27 polymorphisms and ankylosing spondylitis in Han populations: a meta-analysis. Clin Exp Rheumatol 2011, 29:285-292.
5. *2706 protect against ankylosing spondylitis? A meta-analysis. Int J Rheum Dis 2012, 15:8-12.
6. Brewerton D.A., Hart F.D., Nicholls A., Caffrey M., James D.C., Sturrock R.D. Ankylosing spondylitis and HL-A 27. Lancet 1973, 1:904-907.
7. Kushibiki S. Tumor necrosis factor-alpha-induced inflammatory responses in cattle. Anim Sci J 2011, 82:504-511.
8. Pan F., Tian J., Ji C.S., He Y.F., Han X.H., Wang Y., et al. Association of TNF-alpha-308 and -238 polymorphisms with risk of cervical cancer: a meta-analysis. Asian Pac J Cancer Prev 2012, 13:5777-5783.
9. Feng R.N., Liu G.Y., Wang C., Sun C.H., Li Y. TNF polymorphisms and cancer. Asian Pac J Cancer Prev 2012, 13:3007.
10. van Den Berg R., Stanislawska-Biernat E., van der Heijde D.M. Comparison of recommendations for the use of anti-tumour necrosis factor therapy in ankylosing spondylitis in 23 countries worldwide. Rheumatology (Oxford) 2011, 50:2270-2277.
11. Braun J., Baraliakos X., Listing J., Fritz C., Alten R., Burmester G., et al. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response. Ann Rheum Dis 2008, 67:340-345.
12. Francois R.J., Neure L., Sieper J., Braun J. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis 2006, 65:713-720.
13. Braun N., Michel U., Ernst B.P., Metzner R., Bitsch A., Weber F., et al. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production. Neurosci Lett 1996, 215:75-78.
14. Romero-Sanchez C., Londono J., Delgado G., Jaimes D.A., De Avila J., Mora A., et al. Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia. Rheumatol Int 2012, 32:2195-2197.
15. Chung W.T., Choe J.Y., Jang W.C., Park S.M., Ahn Y.C., Yoon I.K., et al. Polymorphisms of tumor necrosis factor-alpha promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population. Rheumatol Int 2011, 31:1167-1175.
16. Sousa E., Caetano-Lopes J., Pinto P., Pimentel F., Teles J., Canhao H., et al. Ankylosing spondylitis susceptibility and severity-contribution of TNF gene promoter polymorphisms at positions -238 and -308. Ann NY Acad Sci 2009, 1173:581-588.
17. Nicknam M.H., Mahmoudi M., Amirzargar A.A., Jamshidi A.R., Rezaei N., Nikbin B. HLA-B27 subtypes and tumor necrosis factor alpha promoter region polymorphism in Iranian patients with ankylosing spondylitis. Eur Cytokine Netw 2009, 20:17-20.
18. Chatzikyriakidou A., Georgiou I., Voulgari P.V., Drosos A.A. The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin Exp Rheumatol 2009, 27:645-648.
19. Lu M.C., Yang K.L., Tung C.H., Huang K.Y., Yu H.C., Liu S.Q., et al. Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with -308G/A polymorphism in promoter region of tumor necrosis factor: association with distinct A33/B58/Cw10 haplotypes. Rheumatol Int 2008, 29:189-195.
20. Zhu X., Wang Y., Sun L., Song Y., Sun F., Tang L., et al. A novel gene variation of TNFalpha associated with ankylosing spondylitis: a reconfirmed study. Ann Rheum Dis 2007, 66:1419-1422.
21. Shiau M.Y., Lo M.K., Chang C.P., Yang T.P., Ho K.T., Chang Y.H. Association of tumour necrosis factor alpha promoter polymorphisms with ankylosing spondylitis in Taiwan. Ann Rheum Dis 2007, 66:562-563.
22. Vargas-Alarcon G., Casasola-Vargas J., Rodriguez-Perez J.M., Huerta-Sil G., Perez-Hernandez N., Londono J., et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 2006, 67:826-832.
23. Gonzalez S., Torre-Alonso J.C., Martinez-Borra J., Fernandez Sanchez J.A., Lopez-Vazquez A., Rodriguez Perez A., et al. TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients. J Rheumatol 2001, 28:1288-1293.
24. Milicic A., Lindheimer F., Laval S., Rudwaleit M., Ackerman H., Wordsworth P., et al. Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis. Genes Immun 2000, 1:418-422.
25. McGarry F., Walker R., Sturrock R., Field M. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J Rheumatol 1999, 26:1110-1116.
26. Fraile A., Nieto A., Beraun Y., Vinasco J., Mataran L., Martin J. Tumor necrosis factor gene polymorphisms in ankylosing spondylitis. Tissue Antigens 1998, 51:386-390.
27. Li B., Wang P., Li H. The association between TNF-alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis. Clin Rheumatol 2010, 29:983-990.
28. Lee Y.H., Song G.G. Lack of association of TNF-alpha promoter polymorphisms with ankylosing spondylitis: a meta-analysis. Rheumatology (Oxford) 2009, 48:1359-1362.
29. Kaijzel E.L., Brinkman B.M., van Krugten M.V., Smith L., Huizinga T.W., Verjans G.M., et al. Polymorphism within the tumor necrosis factor alpha (TNF) promoter region in patients with ankylosing spondylitis. Hum Immunol 1999, 60:140-144.
30. Hohler T., Schaper T., Schneider P.M., Meyer Zum Buschenfelde K.H., Marker-Hermann E. Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 1998, 41:1489-1492.
31. Verjans G.M., Brinkman B.M., Van Doornik C.E., Kijlstra A., Verweij C.L. Polymorphism of tumour necrosis factor-alpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol 1994, 97:45-47.
32. Field M. Tumour necrosis factor polymorphisms in rheumatic diseases. QJM 2001, 94:237-246.
33. Seitz M., Wirthmuller U., Moller B., Villiger P.M. The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxford) 2007, 46:93-96.
34. De Vos M. Review article: joint involvement in inflammatory bowel disease. Aliment Pharmacol Ther 2004, 20(Suppl. 4):36-42.
35. Lee Y.H., Choi S.J., Ji J.D., Song G.G. Associations between interleukin-23R polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Inflamm Res 2012, 61:143-149.
36. Duan Z., Pan F., Zeng Z., Zhang T., Wang S., Li G., et al. Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Rheumatol Int 2012, 32:1209-1214.
37. Lea W.I., Lee Y.H. The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis. Joint Bone Spine 2012, 79:370-374.
38. Chen R., Yao L., Meng T., Xu W. The association between seven ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis involving 8530 cases and 12,449 controls. Rheumatol Int 2012, 32:909-914.
39. Zhan P., Wang J., Wei S.Z., Qian Q., Qiu L.X., Yu L.K., et al. TNF-308 gene polymorphism is associated with COPD risk among Asians: meta-analysis of data for 6,118 subjects. Mol Biol Rep 2011, 38:219-227.
40. Wu L.Y., Zhou Y., Qin C., Hu B.L. The effect of TNF-alpha, FcγR and CD1 polymorphisms on Guillain-Barre syndrome risk: evidences from a meta-analysis. J Neuroimmunol 2012, 243:18-24.
41. Pan H.F., Leng R.X., Wang C., Qin W.Z., Chen L.L., Zha Z.Q., et al. Association of TNF-alpha promoter-308 A/G polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis. Rheumatol Int 2012, 32:2083-2092.
42. Jin X., Wang J., Zhu L., Wang L., Dan H., Zeng X., et al. Association between -308 G/A polymorphism in TNF-alpha gene and lichen planus: a meta-analysis. J Dermatol Sci 2012, 68:127-134.
43. Zhang Y., Zhang J., Tian C., Xiao Y., He C., Li X., et al. The -308 G/A polymorphism in TNF-alpha gene is associated with asthma risk: an update by meta-analysis. J Clin Immunol 2011, 31:174-185.
44. Fan W., Maoqing W., Wangyang C., Fulan H., Dandan L., Jiaojiao R., et al. Relationship between the polymorphism of tumor necrosis factor-alpha-308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis. Eur J Hum Genet 2011, 19:432-437.
45. Touma Z., Farra C., Hamdan A., Shamseddeen W., Uthman I., Hourani H., et al. TNF polymorphisms in patients with Behcet disease: a meta-analysis. Arch Med Res 2010, 41:142-146.
46. Li N., Zhou Z., Liu X., Liu Y., Zhang J., Du L., et al. Association of tumour necrosis factor alpha (TNF-alpha) polymorphisms with Graves' disease: a meta-analysis. Clin Biochem 2008, 41:881-886.